Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
van den Brank HAS, Elliot... |
Radioprotective action of 5-hydroxytryptamine |
Nature |
1958 |
LE Hollister, JJ Prusmack... |
Comparison of three psychotropic drugs (Psilocybin, JB-329, and IT-290... |
J. Nerv. & Ment. Dis... |
1960 |
Doull J, Tricou BJ |
Studies on the radioprotective effect of serotonin in mice |
Fed. Proc. |
1961 |
Fuller RW, Hines CW, Mill... |
Lowering of Brain Serotonin Levels by Chloramphetamines |
Biochem Pharmacol |
1965 |
Eisner BG |
The Importance of the Non-Verbal |
2nd International Co... |
1967 |
Connell PH |
Hallucinogens |
Side effects of drug... |
1972 |
Lopatin DE, Voss EW |
Anti-Lysergic Antibody: Measurement of Binding Parameters in IgG Fract... |
Immunochemistry |
1974 |
Jalfre M, Ruch-Monachon M... |
Methods for Assessing the Interaction of Agents with 5-Hydroxytryptami... |
Advances in Psychoph... |
1974 |
Rappoport M, Cornish H |
The Effect of Two Hallucinogens on in Vivo Concentrations of Cyclic AM... |
Toxicol. appl. Pharm... |
1974 |
Kaplan J, Mandel LR, Stil... |
Blood and urine levels of N,N-dimethyltryptamine following administrat... |
Psychopharmacologia |
1974 |
Yensen R |
The Use of 3, 4 Methylenedioxyamphetamine (MDA) as an Adjunct to Brief... |
Dissertation UC Irvi... |
1975 |
Abrahams SL, Nothup JK, M... |
Adenosine Cyclic 3',5'-Monophosphate in the Liver Fluke, fasciola hepa... |
Molec. Pharmacol. |
1976 |
Belanger M, Chibon P, Cou... |
Etude radiologique des effets du LSD-25 sur l'amphibien pleurodeles wa... |
Compt.Rend.Soc.Biol. |
1976 |
Enna SJ, Bennett JP, Burt... |
Stereospecificity of interaction of neuroleptic drugs with neurotransm... |
Nature |
1976 |
Hamon M, Bourgoin S, Enja... |
The Effects of Quipazine on 5-HT Metabolism in the Rat Brain |
Naunyn Schmiedebergs... |
1976 |
Kehr W |
Effect of Lisuride and Other Ergot Derivatives on Monoaminergic Neurot... |
Arch Pharmacol. |
1977 |
Keller HH, Burkard WP, da... |
Lisuride and D-LSD: Effects on the monoaminergic system in the rat bra... |
Experientia |
1977 |
Mansour TE, Mansour JM |
Phosphodiesterase in the Liver Fluke. Fasciola hevatica |
Biochem.Pharmacol. |
1977 |
Menon MK, Clark WG, Masuo... |
Possible Involvement of the Central Dopaminergic System in the Antires... |
Psychopharmacology |
1977 |
U'Prichard DC, Greenberg ... |
Binding Characteristics of a Radiolabeled Agonist and Antagonist at Ce... |
Mol.Pharmacol. |
1977 |
Waldmeier PC, Maître L |
Neurochemical Investigations of the Interaction of N,N-Dimethyltryptam... |
Psychopharmacology |
1977 |
Levi S, Reisfeld R |
Ultramcrodetermination of Cholesterol, Testosterone and LSD by Fluores... |
Analyt. Chim. Acta |
1978 |
Rech RH |
Brain Lesions and Psychostimulant Drugs |
Psychopharmacol.Bull... |
1978 |
Stolzki B, Kaiser HO, Meh... |
Heterogeneity of LSD Displacing Factors and Multiple Types of High Aff... |
Life Sci. |
1978 |
Marshall DJ, Petersen BA,... |
Some Considerations on Quantitative Methodology and Detection Limits i... |
Biomed. Mass Spectro... |
1978 |
Riceberg LJ, Vunakis HV |
Determination of N,N-dimethylindolealkylamines in plasma, blood and ur... |
J Pharmacol Exp Ther |
1978 |
Geyer MA, Light RK, Rose ... |
A Characteristic Effect of Hallucinogens on Investigatory Responding i... |
Psychopharmacology |
1979 |
Macdermot J, Higashida H |
Independent Regulation of Receptor-Mediated Cell Depolarization and Ad... |
Biochem. Soc. Trans. |
1979 |
Nelson DL, Herbet A, Pich... |
In vitro and in vivo Disposition of 3H-Methiothepin in Brain Tissues. ... |
Arch.Pharmacol. |
1979 |
Samanin R, Mennini T, Fer... |
m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... |
Naunyn-Schmiedeberg'... |
1979 |
Connell DJ, Middlemiss DN... |
Further evidence for an interaction of propranolol with the central 5-... |
Brit.J.Pharmacol. |
1980 |
Nichols DE, Lloyd DH, Hof... |
Effects of certain hallucinogenic amphetamine analogues on the release... |
J Med Chem |
1982 |
Williams M, Martin GE |
Selectivity of cyproheptadine as assessed by radioligand binding |
J. Pharm.Pharmacol. |
1982 |
Whipple MR, Reinecke MG, ... |
Short Communication: Inhibition of Synaptosomal Neurotransmitter Uptak... |
J. Neurochem. |
1983 |
Leino M, Airaksinen MM, A... |
Distribution of 1,2,3,4-tetrahydro-beta-carboline and 6-methoxy-1,2,3,... |
Acta Pharmacol Toxic... |
1984 |
Adams LM, Geyer MA |
Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... |
Prog Neuropsychophar... |
1985 |
Hryhorczuk LM, Rainey JM,... |
A new metabolic pathway for N,N-dimethyltryptamine |
Biol Psychiatry |
1986 |
Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
Sadzot B, Baraban JM, Gle... |
Hallucinogenic drug interactions at human brain 5-HT2 receptors: impli... |
Psychopharmacology (... |
1989 |
Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
Wright JD, Pearl L |
Knowledge and experience of young people regarding drug abuse, 1969-89 |
BMJ |
1990 |
Callaway CW, Johnson MP, ... |
Amphetamine derivatives induce locomotor hyperactivity by acting as in... |
Psychopharmacology (... |
1991 |
Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
Michel RE, Rege AB, Georg... |
High-pressure liquid chromatography/electrochemical detection method f... |
J Neurosci Methods |
1993 |
Rempel NL, Callaway CW, G... |
Serotonin1B receptor activation mimics behavioral effects of presynapt... |
Neuropsychopharmacol... |
1993 |
Norton SA, Ruze P |
Kava Dermopathy |
J Am Acad Dermatol |
1994 |
Wotherspoon G, Savery D, ... |
Repeated administration of MDMA down-regulates preprocholecystokinin m... |
Brain Res Mol Brain ... |
1994 |
Marona-Lewicka D, Rhee GS... |
Psychostimulant-like effects of p-fluoroamphetamine in the rat |
Eur J Pharmacol |
1995 |
Burns N, Olverman HJ, Kel... |
Effects of ecstasy on aldosterone secretion in the rat in vivo and in ... |
Endocr Res |
1996 |
Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
Kombian SB, Zidichouski J... |
GABAB receptors presynaptically modulate excitatory synaptic transmiss... |
J Neurophysiol |
1996 |
Callaway JC, Raymon LP, H... |
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human ... |
J Anal Toxicol |
1996 |
Tillmann HL, van Pelt FN,... |
Accidental intoxication with methylene dianiline p,p'-diaminodiphenylm... |
J Toxicol Clin Toxic... |
1997 |
Marquet P, Lacassie E, Ba... |
Simultaneous determination of amphetamine and its analogs in human who... |
J Chromatogr B Biome... |
1997 |
Piscopo G |
Kava Kava: Gift of the Islands |
Alt Med Rev |
1997 |
Walker TM, Davenport-Jone... |
The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its... |
Cell Biol Toxicol |
1999 |
Laviola G, Adriani W, Ter... |
Psychobiological risk factors for vulnerability to psychostimulants in... |
Neurosci Biobehav Re... |
1999 |
de la Torre R, Farré M, O... |
Non-linear pharmacokinetics of MDMA (`ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
Connor TJ, Kelly JP, McGe... |
Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1b and TNF... |
Life Sci |
2000 |
Connor TJ , Kelly JP, Leo... |
An assessment of the acute effects of the serotonin releasers methylen... |
Immunopharmacology |
2000 |
Beitia G, Cobreros A, Sai... |
Ecstasy-induced Toxicity in Rat Liver |
Liver |
2000 |
Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
Felscher D, Schulz K |
Screening of Amphetamine/Methamphetamine and their Derivatives in Urin... |
J Forensic Sci |
2000 |
Hernandez SC, Bertolino M... |
Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neur... |
J Pharmacol Exp Ther |
2000 |
Lee S-J, Chung H-Y, Lee I... |
Phenolics with Inhibitory Activity on Mouse Brain Monoamine Oxidase (M... |
Food Sci Biotechnol |
2000 |
Ishibashi H, Kuwano K, Ta... |
Inhibition of the 5-HT(1A) receptor-mediated inwardly rectifying K(+) ... |
Neuropharmacology |
2000 |
Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
Mayerhofer A, Kovar KA, S... |
Changes in serotonin, dopamine and noradrenaline levels in striatum an... |
Neuroscience Letters |
2001 |
Connor TJ, Connelly DB, K... |
Methylenedioxymethamphetamine (MDMA, 'Ecstasy') suppresses antigen-spe... |
Immunology Letters |
2001 |
Cannon DM, Keenan AK, Gui... |
In vitro neuronal and vascular responses to 5-HT in rats chronically e... |
Br J Pharmacol |
2001 |
Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
Moeller MR, Kraemer T |
Drugs of abuse monitoring in blood for control of driving under the in... |
Ther Drug Monit |
2002 |
Morley-Fletcher S, Bianch... |
Acute and carryover effects in mice of MDMA ('ecstasy') administration... |
Eur J Pharmacol |
2002 |
Boatto G, Faedda MV, Pau ... |
Determination of amphetamines in human whole blood by capillary electr... |
J Pharm Biomed Anal |
2002 |
Lieb R, Schuetz, CG, Pfis... |
Mental disorders in ecstasy users; A prospective-longitudinal investig... |
Drug Alcohol Depend |
2002 |
Wachtel SR, ElSohly MA, R... |
Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol ... |
Psychopharmacology (... |
2002 |
Meyer A, Mayerhofer A, Ko... |
Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... |
Neurosci Lett |
2002 |
Kupiec T, DeCicco L, Spie... |
Choice of an ELISA assay for screening postmortem blood for amphetamin... |
J Anal Toxicol |
2002 |
Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
Buchert R, Thomasius R, N... |
Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Br... |
J Nucl Med |
2003 |
Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
Schneider RC, Kovar KA |
Analysis of ecstasy tablets: comparison of reflectance and transmittan... |
Forensic Sci Int |
2003 |
Freudenmann RW, Spitzer M |
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-eth... |
CNS Drug Rev |
2004 |
Halpern JH, Pope HG Jr, S... |
Residual neuropsychological effects of illicit 3,4-methylenedioxymetha... |
Drug Alcohol Depend |
2004 |
Wang X, Baumann MH, Xu H,... |
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decrea... |
Synapse |
2004 |
Johansen SS, Jensen JL |
Liquid chromatography-tandem mass spectrometry determination of LSD, I... |
J Chromatogr B Analy... |
2005 |
Ding EL, Hutfless SM, Din... |
Chocolate and prevention of cardiovascular disease: a systematic revie... |
Nutr Metab (Lond) |
2006 |
Safarinejad MR, Hosseini ... |
Safety and efficacy of tramadol in the treatment of premature ejaculat... |
J Clin Psychopharmac... |
2006 |
Williard RL, Middaugh LD,... |
Methylphenidate and its ethanol transesterification metabolite ethylph... |
Behav Pharmacol |
2007 |
Alves E, Summavielle T, A... |
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Ado... |
J Neuroscience |
2007 |
Schifano F, Corkery J, Na... |
Overview of Amphetamine-Type Stimulant Mortality Data - UK, 1997-2007 |
Neuropsychobiology |
2010 |
Brandt SD, Sumnall HR, Me... |
Analyses of second-generation 'legal highs' in the UK: Initial finding... |
Drug Test Anal |
2010 |
Cozzi NV, Mavlyutov TA, T... |
Indolethylamine N-methyltransferase expression in primate nervous tiss... |
Soc. Neurosci. |
2011 |
Casselman I, Heinrich M |
Novel Use Patterns of Salvia divinorum: Unobtrusive Observation using ... |
Journal of Ethnophar... |
2011 |
Gibbons S |
'Legal Highs' - novel and emerging psychoactive drugs: a chemical over... |
Clin Toxicol (Phila) |
2012 |
Lurie Y, Gopher A, Lavon ... |
Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (P... |
Clin Toxicol (Phila) |
2012 |
Carhart-Harris RL, Leech ... |
Implications for psychedelic-assisted psychotherapy: a functional magn... |
Br J Psychiatry |
2012 |